Evan Tzanis

Chief Operating Officer at Neuraptive Therapeutics, Inc.

Health Technology

Profile

Evan Tzanis is currently the COO and Executive VP of Research & Development at Neuraptive Therapeutics, Inc. He previously worked as the Head of Clinical Operations & Biometrics at Endo Pharmaceuticals, Inc. from 2011 to 2014.
He also served as the Vice President of Clinical Development at Paratek Pharmaceuticals, Inc. from 2014 to 2017.

Evan Tzanis active positions

Companies	Position	Start
Neuraptive Therapeutics, Inc. Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co.	Chief Operating Officer	2022-10-23

All active positions of Evan Tzanis

Former positions of Evan Tzanis

Companies	Position	End
Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.	Corporate Officer/Principal	2014-07-31
PARATEK PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Evan Tzanis's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Evan Tzanis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PARATEK PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.	Health Technology
Neuraptive Therapeutics, Inc. Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co.	Health Technology